Shoji Okinaga

10.4k citations
49 papers · 3.8k indexed · 1 hit paper · h-index 26

Shoji Okinaga

47 papers receiving 3.7k citations

Hit Papers

Updated overall survival results from a randomized phase ...4272012202620162021100200300400

Peers

Shoji Okinaga
Comparison fields: 5 of 129
  • Pulmonary and Respiratory Medicine 1.6k
  • Oncology 1.1k
  • Critical Care and Intensive Care Medicine 178
  • Immunology 642
  • Cell Biology 440
Replace Kathleen J. Haley with:
Kathleen J. Haley United States
András Kiss Hungary
Kentaro Tanaka Japan
Patty J. Lee United States
Michio Ogawa Japan
Rachel L. Zemans United States
Rory E. Morty Germany
David H. Ingbar United States
Tetsuo Hayakawa Japan
Andreas Herbst Sweden
Shoji Okinaga relative to Kathleen J. Haley United States Kathleen J. Haley's profile →
Citations per field
00.5×3.0×
Kathleen J. Haley · 1×
Citations per year

Countries citing papers authored by Shoji Okinaga

Since Specialization
Citations

This map shows the geographic impact of Shoji Okinaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoji Okinaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoji Okinaga more than expected).

Fields of papers citing papers by Shoji Okinaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoji Okinaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoji Okinaga. The network helps show where Shoji Okinaga may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shoji Okinaga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shoji Okinaga Line = papers co-authored together Shoji Okinaga links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20170
2 201631
3 20165
4 201523
5 201334
6
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)breakdown →
2012427
7 20112
8 2009369
9 2009156
10
Nitroglycerin treatment may increase response to docetaxel and carboplatin regimen via inhibitions of hypoxia-inducible factor-1 pathway and P-glycoprotein in patients with lung adenocarcinoma
20069
11 200556
12 2002117
13 20011
14 2000471
15 199826
16 19989
17 1997231
18 19965
19 199141
20 1989168

About Shoji Okinaga

Shoji Okinaga is a scholar working on Critical Care and Intensive Care Medicine, Endocrine and Autonomic Systems and Emergency Medical Services, having authored 49 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Heme Oxygenase-1 and Carbon Monoxide (10 papers), Lung Cancer Research Studies (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Asthma and respiratory diseases (8 papers), Thermal Regulation in Medicine (5 papers), RNA regulation and disease (5 papers) and melanin and skin pigmentation (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.6k citations), Oncology (1.1k citations) and Critical Care and Intensive Care Medicine (178 citations). Shoji Okinaga has collaborated with scholars based in Japan, South Korea and United States. Frequent co-authors include Shigeki Shibahara, Hidetada Sasaki, Mutsuo Yamaya, Kiyohisa Sekizawa, Norihiro Yamada, Katsutoshi Nakayama, Norma P. Gerard, Takashi Ohrui, Koichi Hagiwara and Makoto Maemondo.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026